Decheng Capital Management III »

Lantheus Holdings Inc Common Stock Usd 0.01 shares owned by Decheng Capital Management III

Quarter-by-quarter ownership of Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) shares owned by Decheng Capital Management III from 13F filings

Historical chart of Decheng Capital Management III investment in Lantheus Holdings Inc Common Stock Usd 0.01

Tip: Access up to 7 years of quarterly data

All positions including Lantheus Holdings Inc Common Stock Usd 0.01 held by Decheng Capital Management III consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lantheus Holdings Inc Common Stock Usd 0.01 by Decheng Capital Management III

Quarter filed Position value Share count Share price at filing
2023-09-30 $9.9M 142k 69.48

More positions owned by Decheng Capital Management III

Alpine Immune Sciences
Zentalis Pharmaceuticals (ZNTL)
Aura Biosciences (AURA)
Roivant Sciences Ltd Shs Isin #bmg762791017 (ROIV)
Acelyrin (SLRN)
Arcus Biosciences Incorporated (RCUS)
10x Genomics Cl A Com (TXG)
Argenx SE SHS (ARGX)
Pacific Biosciences of California (PACB)
Illumina (ILMN)
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH)
Horizon Therapeutics
Phathom Pharmaceuticals (PHAT)
ImmunoGen
Seagen

View all positions for Decheng Capital Management III

Top funds holding Lantheus Holdings Inc Common Stock Usd 0.01

BlackRock
Invesco
Geode Capital Management
Westfield Capital Management Company
Reinhart Mahoney Capital Management
Dimensional Fund Advisors
T. Rowe Price Associates
Lazard Asset Management
T. Rowe Price Investment Management
Northern Trust
Charles Schwab Investment Management
Swedbank AB
Bank of America Corporation
Jpmorgan Chase & Co
Bank of New York Mellon

View all funds holding Lantheus Holdings Inc Common Stock Usd 0.01